课题基金 / 基金详情

Study about the elucidation of hepatocarcinogenesis mechanism km fatty liver and preventive strategies based on pathogenic considerations

Study about the elucidation of hepatocarcinogenesis mechanism km fatty liver and preventive strategies based on pathogenic considerations
脂肪肝肝癌发生机制的阐明及基于病因的预防策略研究
批准号:
18590574
负责人:
WATANABE Tetsu
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

WATANABE Tetsu的其他基金

相似基金

相关文献

中文摘要
翻译
本研究选用FLS小鼠(n=48)。无肥胖的FLS小鼠慢性自发性脂肪肝。肝脏肿瘤发生在1岁以后。FLS小鼠再分为3组:1组饲喂单独的对照饲粮(CA-1), 2组饲喂含有乳酸菌的饲粮,3组饲喂含丁酸梭菌的对照饲粮,丁酸梭菌经口服后在肠道内产生丁酸。10月龄时,所有小鼠肝脏均有明显脂肪沉积,无纤维化。12月龄时,1组8只小鼠中有2只发生肝脏肿瘤,而2组和3组8只小鼠中均有1只发生肝脏肿瘤。高效液相色谱法测定小鼠粪便中的短链脂肪酸,结果显示,3组小鼠的丁酸钠浓度升高。10月龄LPS小鼠肝脏免疫组化分析显示,与3组小鼠相比,1组小鼠肝脏氧化应激标志物4-HNE显著升高。Western blot结果显示,3组小鼠肝脏中转录因子NF-KB蛋白表达增加。第3组小鼠肝脏中c-jun (Ser 73)也出现磷酸化。Western blot结果显示,3组小鼠肝脏p21 WAF1蛋白表达也明显升高。这些结果表明氧化应激在FLS小鼠肝脏疾病的进展中起着至关重要的作用。口服丁酸梭菌可保护FLS小鼠肝脏肿瘤的发生。
英文摘要
We used FLS mice (n=48) in this study. FLS mouse develops spontaneously fatty liver chronically without obesity. Liver tumors develop after age of 1 year. The FLS mice were subdivided into three groups : group 1 received control diet (CA-1) alone, group 2 received diet containing lactobacillus, and group 3 received control diet containing clostridium butyricum that produce butyric acid in a bowel after oral intake.At age 10 month, all mice showed significant fatty deposition in the liver without fibrosis. At age 12 month, 2 out of 8 mice in group 1 developed liver tumor, whereas 1 out of 8 mice developed liver tumor in both group 2 and 3. Measurement of short chain fatty acid in the feces by HPLC revealed that concentration of sodium butyrate increased in the mice of group 3.Immunohistochemical analysis of the liver of 10-month-old LPS mice showed that 4-HNE, a marker of oxidative stress, remarkably increased in group 1 mice compared with those in group 3 mice. On the contrary, the protein expression of transcription factor NF-KB increased in the liver of group 3 mice by the Western blot analysis. Phosphorylation of c-jun (Ser 73) was also observed in the liver of mice in group 3. Finally, protein expression of p21 WAF1 also increased in the liver of group 3 mice by the Western blot.These results indicate that oxidative stress takes a crucial role in the progression of liver disease in FLS mice. Oral intake of clostridium butyricum may protect the development of liver tumor in FLS mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/hep.21477
发表时间: 2007-01-01
期刊: HEPATOLOGY
影响因子: 13.5
作者: [Higashiyama, Reiichi, Inagaki, Yutaka, Okazaki, Isao]
通讯作者: Okazaki, Isao
肝線維化に対する薬物療法:NAFLDのすべて,第6章,病態生理に基づくNAFLDの薬物療法
肝纤维化的药物治疗:关于 NAFLD,第 6 章,基于病理生理学的 NAFLD 药物治疗
DOI: --
发表时间: 2006
期刊: 医学のあゆみ 別冊
影响因子: --
作者: [Reiichi, Higashiyama, et. al., 渡辺 哲, Higashiyama R, 渡辺 哲]
通讯作者: 渡辺 哲
All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPI3-LIP
全反式视黄酸通过诱导 C/EBPI3-LIP 下调人白蛋白基因表达
DOI: --
发表时间: 2006
期刊: Biochem J 397
影响因子: --
作者: [Takahiro, Masaki, et. al.]
通讯作者: et. al.
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Reiichi, Higashiyama, et. al.]
通讯作者: et. al.
共 12 条
    Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signaling
    • 批准号:
      16K09490
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      WATANABE Tetsu
    • 依托单位:
    Probiotics and prevention of hepatocarcinogenesis
    • 批准号:
      26460810
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      WATANABE Tetsu
    • 依托单位:
    The impact of macrophage transcription factor MafB on rupture of abdominal aortic aneurysm
    • 批准号:
      24591033
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      WATANABE Tetsu
    • 依托单位:
    Development of a method for preventing NASH progression and hepatocarcinogenesis by using butyrate-produding probiotics
    • 批准号:
      23590755
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2011
    • 负责人:
      WATANABE Tetsu
    • 依托单位:
    海外基金